La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Zhejiang Wolwo Bio-Pharmaceutical Dividende
Dividende contrôle des critères 3/6
Zhejiang Wolwo Bio-Pharmaceutical is a dividend paying company with a current yield of 1% that is well covered by earnings.
Informations clés
1.0%
Rendement du dividende
31%
Ratio de distribution
| Rendement moyen de l'industrie | 1.9% |
| Prochaine date de paiement du dividende | n/a |
| Date ex-dividende | n/a |
| Dividende par action | CN¥0.185 |
| Résultat par action | CN¥0.61 |
| Prévisions de rendement du dividende à 3 ans | 0% |
Mises à jour récentes des dividendes
Recent updates
Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) Has Announced That Its Dividend Will Be Reduced To CN¥0.185
Jun 30
Investor Optimism Abounds Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357) But Growth Is Lacking
May 27Calculating The Fair Value Of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357)
May 07Is Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) A Risky Investment?
Mar 22Stabilité et croissance des paiements
Récupération des données sur les dividendes
Dividende stable: 300357 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Dividende croissant: 300357's dividend payments have increased, but the company has only paid a dividend for 9 years.
Rendement des dividendes par rapport au marché
| Zhejiang Wolwo Bio-Pharmaceutical Rendement des dividendes par rapport au marché |
|---|
| Segment | Rendement du dividende |
|---|---|
| Entreprise (300357) | 1.0% |
| 25% du marché (CN) | 0.7% |
| 25% du marché (CN) | 2.6% |
| Moyenne du secteur (Pharmaceuticals) | 1.9% |
| Prévisions des analystes dans 3 ans (300357) | 0% |
Dividende notable: 300357's dividend (1%) is higher than the bottom 25% of dividend payers in the CN market (0.73%).
Dividende élevé: 300357's dividend (1%) is low compared to the top 25% of dividend payers in the CN market (2.63%).
Bénéfice distribué aux actionnaires
Couverture des revenus: With its reasonably low payout ratio (30.6%), 300357's dividend payments are well covered by earnings.
Paiement en espèces aux actionnaires
Couverture des flux de trésorerie: With its reasonable cash payout ratio (66.9%), 300357's dividend payments are covered by cash flows.